Insmed | INSM - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Cytokinetics USD 8.19B 420M 2026-03
DBV Technologies USD 629M 601M 2026-07
Gilead Sciences USD 172.99B 20.71B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 35.3B 1.82B 2026-03
Novartis USD 319.89B 31.63B 2026-07
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03